Suppression of type II collagen-induced arthritis by the intravenous administration of type II collagen or its constituent peptide α1, (II) CB10

Mary E. Englert, Mary Jane Landes, Arnold L. Oronsky, S. S. Kerwar

Research output: Contribution to journalArticle

Abstract

Intravenous administration of Type II collagen to rats prior to immunization with Type II collagen suppresses hind paw inflammation, humoral response to Type II collagen, and the severity of the arthritic lesion. Suppression of inflammation and its severity as well as the humoral response can also be induced by the prior intravenous administration of α1 (II) CB10 a cyanogen bromide peptide derived from Type II collagen. Suppression of arthritis is disease specific; intravenous administration of either Type II collagen or α1 (II) CB10 does not have an effect on adjuvant-induced arthritis. These studies indicate that structural determinants of α1 (II) CB10 (Mr, 30,000), a peptide located near the carboxy terminus of the collagen molecule, can induce suppression and suggest that these determinants may be responsible for the suppression of arthritis when Type II collagen is administered intravenously.

Original languageEnglish (US)
Pages (from-to)357-365
Number of pages9
JournalCellular Immunology
Volume87
Issue number2
DOIs
StatePublished - 1984
Externally publishedYes

Fingerprint

Experimental Arthritis
Collagen Type II
Intravenous Administration
Peptides
Arthritis
Inflammation
Cyanogen Bromide
Immunization
Collagen

ASJC Scopus subject areas

  • Cell Biology
  • Immunology

Cite this

Suppression of type II collagen-induced arthritis by the intravenous administration of type II collagen or its constituent peptide α1, (II) CB10. / Englert, Mary E.; Landes, Mary Jane; Oronsky, Arnold L.; Kerwar, S. S.

In: Cellular Immunology, Vol. 87, No. 2, 1984, p. 357-365.

Research output: Contribution to journalArticle

Englert, Mary E. ; Landes, Mary Jane ; Oronsky, Arnold L. ; Kerwar, S. S. / Suppression of type II collagen-induced arthritis by the intravenous administration of type II collagen or its constituent peptide α1, (II) CB10. In: Cellular Immunology. 1984 ; Vol. 87, No. 2. pp. 357-365.
@article{610b7137523346b0a1d943af30285355,
title = "Suppression of type II collagen-induced arthritis by the intravenous administration of type II collagen or its constituent peptide α1, (II) CB10",
abstract = "Intravenous administration of Type II collagen to rats prior to immunization with Type II collagen suppresses hind paw inflammation, humoral response to Type II collagen, and the severity of the arthritic lesion. Suppression of inflammation and its severity as well as the humoral response can also be induced by the prior intravenous administration of α1 (II) CB10 a cyanogen bromide peptide derived from Type II collagen. Suppression of arthritis is disease specific; intravenous administration of either Type II collagen or α1 (II) CB10 does not have an effect on adjuvant-induced arthritis. These studies indicate that structural determinants of α1 (II) CB10 (Mr, 30,000), a peptide located near the carboxy terminus of the collagen molecule, can induce suppression and suggest that these determinants may be responsible for the suppression of arthritis when Type II collagen is administered intravenously.",
author = "Englert, {Mary E.} and Landes, {Mary Jane} and Oronsky, {Arnold L.} and Kerwar, {S. S.}",
year = "1984",
doi = "10.1016/0008-8749(84)90005-4",
language = "English (US)",
volume = "87",
pages = "357--365",
journal = "Cellular Immunology",
issn = "0008-8749",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Suppression of type II collagen-induced arthritis by the intravenous administration of type II collagen or its constituent peptide α1, (II) CB10

AU - Englert, Mary E.

AU - Landes, Mary Jane

AU - Oronsky, Arnold L.

AU - Kerwar, S. S.

PY - 1984

Y1 - 1984

N2 - Intravenous administration of Type II collagen to rats prior to immunization with Type II collagen suppresses hind paw inflammation, humoral response to Type II collagen, and the severity of the arthritic lesion. Suppression of inflammation and its severity as well as the humoral response can also be induced by the prior intravenous administration of α1 (II) CB10 a cyanogen bromide peptide derived from Type II collagen. Suppression of arthritis is disease specific; intravenous administration of either Type II collagen or α1 (II) CB10 does not have an effect on adjuvant-induced arthritis. These studies indicate that structural determinants of α1 (II) CB10 (Mr, 30,000), a peptide located near the carboxy terminus of the collagen molecule, can induce suppression and suggest that these determinants may be responsible for the suppression of arthritis when Type II collagen is administered intravenously.

AB - Intravenous administration of Type II collagen to rats prior to immunization with Type II collagen suppresses hind paw inflammation, humoral response to Type II collagen, and the severity of the arthritic lesion. Suppression of inflammation and its severity as well as the humoral response can also be induced by the prior intravenous administration of α1 (II) CB10 a cyanogen bromide peptide derived from Type II collagen. Suppression of arthritis is disease specific; intravenous administration of either Type II collagen or α1 (II) CB10 does not have an effect on adjuvant-induced arthritis. These studies indicate that structural determinants of α1 (II) CB10 (Mr, 30,000), a peptide located near the carboxy terminus of the collagen molecule, can induce suppression and suggest that these determinants may be responsible for the suppression of arthritis when Type II collagen is administered intravenously.

UR - http://www.scopus.com/inward/record.url?scp=0021275619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021275619&partnerID=8YFLogxK

U2 - 10.1016/0008-8749(84)90005-4

DO - 10.1016/0008-8749(84)90005-4

M3 - Article

C2 - 6467383

AN - SCOPUS:0021275619

VL - 87

SP - 357

EP - 365

JO - Cellular Immunology

JF - Cellular Immunology

SN - 0008-8749

IS - 2

ER -